- Home
- LNTH vs CNX Comparison
LNTH vs CNX Comparison
Compare LNTH & CNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNTH | CNX |
|---|---|---|
| Founded | 1956 | 1860 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.8B |
| IPO Year | 2014 | 1998 |
Fundamental Metrics
Financial Performance| Metric | LNTH | CNX |
|---|---|---|
| Price | $76.10 | $38.71 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 6 | 7 |
| Target Price | ★ $83.20 | $35.71 |
| AVG Volume (30 Days) | 958.1K | ★ 1.9M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 763.33 |
| EPS | 3.41 | ★ 3.98 |
| Revenue | $343,374,000.00 | ★ $2,239,134,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.93 | $11.01 |
| P/E Ratio | $22.31 | ★ $9.71 |
| Revenue Growth | 3.62 | ★ 76.76 |
| 52 Week Low | $47.27 | $27.68 |
| 52 Week High | $108.86 | $43.62 |
Technical Indicators
Market Signals| Indicator | LNTH | CNX |
|---|---|---|
| Relative Strength Index (RSI) | 51.22 | 40.43 |
| Support Level | $72.33 | $36.33 |
| Resistance Level | $84.77 | $42.50 |
| Average True Range (ATR) | 2.47 | 1.63 |
| MACD | -0.58 | -0.36 |
| Stochastic Oscillator | 40.96 | 18.29 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About CNX CNX Resources Corporation
CNX Resources Corp is an independent natural gas development, production, midstream and technology company centered in the Appalachian Basin. It is focused on unconventional shale formations, prominently the Marcellus Shale and Utica Shale, in Pennsylvania, Ohio and West Virginia. Additionally, the company operates and develops Coalbed Methane (CBM) properties in Virginia. the company has two reportable segments: Shale and Coalbed Methane. The majority of the company's revenue is derived from the Shale segment.